NCT00950664 - A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia | Biotech Hunter

Enrollment

103

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

July 31, 2011

Conditions

Cervical Dystonia

Interventions

DRUG

Dysport® (abobotulinumtoxinA)

Cross over injection of Dysport® (\<500IU), Botox® (200IU)assuming a bioequivalence ratio of 2.5:1 units

DRUG

Botox® (onabotulinumtoxinA)

Cross over injection of Dysport® (\<500IU), Botox® (200IU)assuming a bioequivalence ratio of 2.5:1 units

Trial Locations (7)

Bundang Seoul Natiuonal University Hospital, Seongnam-si

Dong-A University Hospital, Busan

Hanyang University Hospital, Seoul

Samsung Medical Center, Seoul

Asan Medical Center, Seoul

Boramae City Hospital, Seoul

Seoul National University Hospital, Seoul